This article is a correction to:
Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports
Qiang Chen
Yunxuan Zhang
Chenyu Sun
Li Liu1
Xiaoyan Luo
Sili Ni- 1Department of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China
- 2Department of Pediatrics, Chongqing University Three Gorges Hospital, Chongqing, China
- 3Department of Burn and Plastic Surgery, Children’s Hospital of Chongqing Medical University, Chongqing, China
- 4AMITA Health Saint Joseph Hospital Chicago, University of Illinois at Chicago, Chicago, IL, United States
A Corrigendum on
Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
by Chen Q, Zhang Y, Sun C, Liu L, Luo X, Wang H and Ni S (2022) Front. Oncol. 12:1000099. doi: 10.3389/fonc.2022.1000099
Incorrect Affiliation
In the published article, there was an error in affiliation 1. Instead of “Department of Dermatology, Children’s Hospital of Chongqing Medical University, Chongqing, China” it should be “Department of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China”.
In the published article, there was an error in affiliation 4. Instead of “AMITA Health Saini Joseph Hospital Chicago, University of lllinois at Chicago, Chicago, IL, United States” it should be “AMITA Health Saint Joseph Hospital Chicago, University of Illinois at Chicago, Chicago, IL, United States”.
The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: infantile hemangioma, recurrence, propranolol, β2-adrenergic receptor, salbutamol, procaterol
Citation: Chen Q, Zhang Y, Sun C, Liu L, Luo X, Wang H and Ni S (2023) Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports. Front. Oncol. 13:1282607. doi: 10.3389/fonc.2023.1282607
Received: 24 August 2023; Accepted: 25 August 2023;
Published: 08 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Chen, Zhang, Sun, Liu, Luo, Wang and Ni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sili Ni, 38962149@qq.com
†These authors share first authorship